Cibc World Markets Corp Guardant Health, Inc. Transaction History
Cibc World Markets Corp
- $12.4 Billion
- Q1 2025
A detailed history of Cibc World Markets Corp transactions in Guardant Health, Inc. stock. As of the latest transaction made, Cibc World Markets Corp holds 27,253 shares of GH stock, worth $1.35 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
27,253
Previous 11,342
140.28%
Holding current value
$1.35 Million
Previous $346,000
235.26%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding GH
# of Institutions
393Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$598 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$557 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$270 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$255 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$251 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $5.06B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...